to apply for authorization. there was an add layer as you mentioned, which is that they were encouraged to apply for authorization which gives a sense that the regulators have seen something encouraging in the date. a the only thing we heard until today, late last night, was that the two doses in children between amings of 2 and 5 did not seem to be generating a strong immune response. so i don't know if the regulators are saying we're very encouraged that a third dose will be enough to generate that immune response but we don't want to wait for the third dose data. we think it is time get moving and hopefully get two doses out there. we don't know. hopefully when the fda looks at this data, they release it, we'll get a better sense of what's going on. >> are there any risks at all, kids this small, 6 months to 5 years old, getting the vaccine? >> according to the company, that's the only data, the only sense we have of things. we haven't seen the data. they say there has not been